David Ruano-Gallego
7PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 02, 2025
The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomes.Priyanka Biswas, Julia Sanchez-Garrido, Zuzanna Kozik
|Mar 14, 2024
Immunoanalytical Detection of Conserved Peptides: Refining the Universe of Biomarker Targets in Planetary Exploration.Pedro Mustieles-Del-Ser, David Ruano-Gallego, Víctor Parro
|Apr 30, 2021
A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS-CoV-2 reveals higher seroprevalence than reported.David Ruano-Gallego, Miriam García-Villadangos, Mercedes Moreno-Paz
|Mar 12, 2021
Type III secretion system effectors form robust and flexible intracellular virulence networks.David Ruano-Gallego, Julia Sanchez-Garrido, Zuzanna Kozik
|Aug 30, 2019
A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa.David Ruano-Gallego, Daniel A Yara, Lorenza Di Ianni
|Dec 01, 2018
Author Correction: Host-associated niche metabolism controls enteric infection through fine-tuning the regulation of type 3 secretion.James P R Connolly, Sabrina L Slater, Nicky O'Boyle
Pageof 2
Frequent Collaborators
4 joint publications
Gad Frankel
2 joint publications
James P R Connolly
2 joint publications
David G E Smith
2 joint publications
Luis Ángel Fernández
2 joint publications
Julia Sanchez-Garrido
2 joint publications
Zuzanna Kozik
1 joint publications
Daniel A Yara
1 joint publications
Lorenza Di Ianni
1 joint publications
Stephanie Schüller
1 joint publications
Elena Núñez-Berrueco
